Article
The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling.
Leukemia - 1 Mar 2018
Girardi T, Vereecke S, Sulima S O, Khan Y, Fancello L, Briggs J W, Schwab C, de Beeck J Op, Verbeeck J, Royaert J, Geerdens E, Vicente C, Bornschein S, Harrison C J, Meijerink J P, Cools J, Dinman J D, Kampen K R, De Keersmaecker K
Abstract excerpt
Several somatic ribosome defects have recently been discovered in cancer, yet their oncogenic mechanisms remain poorly understood. Here we investigated the pathogenic role of the recurrent R98S mutation in ribosomal protein L10 (RPL10 R98S) found in T-cell acute lymphoblastic leukemia (T-ALL). The JAK-STAT signaling pathway is a critical controller of cellular proliferation and survival. A proteome screen...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
